References
- Bardi, E., Bodok, I., Olah, A. V., Kappelmayer, J., Kiss, C. (2007). Anthracycline induce acute renal tubular toxicity in children with cancer. Pathol Oncol Res 13:249–253.
- Bassioukas, K., Katopodis, K., Christophorou, N., et al. (2006). Acute renal failure induced by intravenous acyclovir. J Eur Acad Dermatol Venereol 20:1151–1152.
- Becker, B. N., Fall, P., Hall, C., et al. (1993). Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature. Am J Kidney Dis 22: 611–615.
- Campos, S. B., Seguro, A. C., Cesar, K. R., Rocha, A. (1992). Effects of acyclovir on renal function. Nephron 62:74–79.
- Inaba, H., Jones, D. P., Gaber, L. W., Shenep, J. L., Call, S. K., Pui, C-H., et al. (2007). BK virus-induced tubulointerstitial nephritis in a child with acute lymphoblastic leukemia. J Pediatr 151:215–217.
- Isoda, T., Ito, S., Kajiwara, M., Nagasawa, M. (2007). Successful high-dose chemotherapy in a patient with acute lymphoblastic leukemia who developed acute renal failure during initial treatment. Pediatr Int 49:1018–1019.
- Johnson, G. L., Limon, L., Trikha, G., et al. (1994). Acute renal failure and neurotoxicity following oral acyclovir. Ann Pharmacother 28:460–463.
- Kaya, Z., Gursel, T., Bakkaloglu, S. A., Kocak, U., Atasever, T., Oktar, S. O. (2007). Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol 24:257–267.
- Keeney, R. E., Kirk, R. E., Brigden, D. (1982). Acyclovir tolerance in humans. Am J Med 72:176–181.
- Krawczuk-Rybak, M., Kuzmicz, M., Wysocka, J. (2005). Renal function during and after treatment for acute lymphoblastic leukemia in children. Pediatr Nephrol 20:782–785.
- Krieble, B. F., Rudy, D. W., Glick, M. R., et al. (1993). Acyclovir neurotoxicity and nephrotoxicity: the role for hemodialysis [case report]. Am J Med Sci 305:36–39.
- Müller-Suur, R., Gutsche, H. U. (1995). Tubular reabsorption of technetium-99m DMSA. J Nucl Med 36:1654–1658.
- Naranjo, C. A., Busto, U., Sellers, E. M., et al. (1981). A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245.
- Saha, G. B. (2004). Fundementals of Nuclear Pharmacy, 5th ed (pp 285–286). New York: Springer.
- Santos, M. F. F., Santos, O. F. P., Boim, M. A. (1997). Nephrotoxicity of acyclovir and gancyclovir in rats. Evaluation of glomerular hemodynamics. J Am Soc Nephrol 8:361–367.
- Sawyer, M. H., Webb, D. E., Balow, J. E., Straus, S. E. (1988). Acyclovir-induced renal failure. Clinical course and histology. Am J Med 84:1067–1071.
- Schreiber, R., Wolpin, J., Koren, G. (2008). Determinants of aciclovir-induced nephrotoxicity in children. Paediatr Drugs 10:135–139.
- Tucker, W. E. (1982). Preclinical toxicology profile of acyclovir: an overview. Am J Med 73:27–30.
- Vomiero, G., Carpenter, B., Robb, I., Filler, G. (2002). Combination of ceftriaxone and acyclovir—an underestimated nephrotoxic potential? Pediatr Nephrol 17:633–637.
- Yetgin, S., Olgar, S., Aras, T., et al. (2004). Evaluation of kidney damage in patients with acute lymphoblastic leukemia in long-term follow-up: value of renal scan. Am J Hematol 77:132–139.